News
PharmaCyte Biotech
PMCB · NASDAQ
$0.3422+$0.0002 (+0.06%)TodayMarket closed ·
Prev close $0.342
Latest news
- News
12 Health Care Stocks Moving In Tuesday's After-Market Session
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- NewsAvi Kapoor
Why Autodesk Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
- Press releaseBusiness Wire
PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
- News
PharmaCyte Biotech Q1 EPS $(1.23) Down From $1.90 YoY
- Press releaseBusiness Wire
PharmaCyte Biotech, Inc. Increases Stake in TNF Pharmaceuticals Around Recent License for Breakthrough Light Speed Computing Platform for Use in Cryptocurrency Applications
- Press releaseBusiness Wire
PharmaCyte Biotech, Inc. Announces Closing of $7 Million Financing
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Press releaseBusiness Wire
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors
- News
PharmaCyte Biotech Q4 EPS $1.54 Up From $(0.33) YoY
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.